Arteris, Inc. reported its financial results for the first quarter of 2025, revealing a total revenue of $16.5 million, a 28% increase from $12.9 million in the same period last year. The growth was primarily driven by a 31% rise in licensing, support, and maintenance revenue, which reached $15.3 million, up from $11.7 million. Variable royalties also saw a significant increase of 43%, totaling $1.2 million compared to $0.8 million in the prior year. Despite the revenue growth, the company reported a net loss of $8.1 million, slightly improved from a net loss of $9.4 million in the first quarter of 2024.
In terms of operational metrics, Arteris had 270 full-time employees as of March 31, 2025, and reported 17 Confirmed Design Starts during the quarter. The company’s Annual Contract Value (ACV) increased to $62.1 million, up from $53.5 million a year earlier, while the total ACV plus royalties rose to $66.8 million from $58.2 million. The company continues to focus on expanding its customer base and enhancing its product offerings, particularly in the semiconductor industry, which is characterized by rapid technological advancements and increasing complexity in System-on-Chip (SoC) designs.
Arteris also noted a decrease in its stockholders' deficit, which widened to $(4.8 million) from $(1.2 million) at the end of 2024. The company’s cash and cash equivalents increased to $16.4 million from $13.7 million at the end of the previous fiscal year. The filing indicated that the company is committed to investing in research and development, with R&D expenses rising to $11.9 million, a 9% increase from the prior year, reflecting higher employee-related costs and professional fees.
Looking ahead, Arteris expressed optimism about its growth trajectory, driven by the increasing demand for sophisticated semiconductor solutions in various markets, including automotive and artificial intelligence. However, the company acknowledged potential challenges, including market volatility and geopolitical tensions that could impact its operations and customer demand. The management emphasized the importance of securing new license agreements and maintaining strong relationships with existing customers to sustain revenue growth.
Overall, Arteris, Inc. continues to navigate a competitive landscape while focusing on expanding its market share and enhancing its product offerings, despite the ongoing challenges in the semiconductor industry.
About Arteris, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.